Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome

The present invention relates to the use of prolonged release combinations of hydromorphone hydrochloride and naloxone hydrochloride in a weight ratio corresponding to about 1:2 of hydromorphone HCl:naloxone HCl for the preparation of a medicament for the treatment of pain in a patient, wherein the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krishnamurthy Thinnayam Naganathan, Whitehouse Jonathon Oliver, Danagher Helen Kathleen, Walden Malcolm, Mohammad Hassan, Hayes Geoffrey Gerard, Vargas Rincon Ricardo Alberto
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to the use of prolonged release combinations of hydromorphone hydrochloride and naloxone hydrochloride in a weight ratio corresponding to about 1:2 of hydromorphone HCl:naloxone HCl for the preparation of a medicament for the treatment of pain in a patient, wherein the medicament is formulated for oral administration of hydromorphone hydrochloride in a daily amount corresponding to from and including about 24 mg up to and including about 48 mg of hydromorphone hydrochloride, and naloxone hydrochloride in a daily amount corresponding to from and including about 48 mg up to and including about 96 mg of naloxone hydrochloride.